Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7990278 | 1.00 | DPP4 (0.36) | DPP4SLC7A5EPHX2ALDH1A1LMNA | |
| SCHEMBL7994206 | 0.82 | DPP4 (0.47) | DPP4SLC7A5ALDH1A1LMNAABCC4 | |
| SCHEMBL7994208 | 0.82 | DPP4 (0.47) | DPP4SLC7A5ALDH1A1LMNAABCC4 | |
| SCHEMBL7986467 | 0.77 | DPP4 (0.46) | DPP4SLC7A5EPHX2ALDH1A1LMNA | |
| SCHEMBL7986473 | 0.77 | DPP4 (0.46) | DPP4SLC7A5EPHX2ALDH1A1LMNA | |
| SCHEMBL7986822 | 0.76 | EPHX2 (0.32) | EPHX2ALDH1A1LMNAABCC4MAPT | |
| SCHEMBL7986849 | 0.75 | DPP4 (0.32) | DPP4 | |
| SCHEMBL7986851 | 0.75 | DPP4 (0.32) | DPP4 | |
| SCHEMBL7990372 | 0.71 | ALDH1A1 (0.33) | DPP4ALDH1A1LMNAABCC4MAPT | |
| SCHEMBL7990370 | 0.71 | ALDH1A1 (0.33) | DPP4ALDH1A1LMNAABCC4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001040198-A2 | MACROCYCLIC HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS ANTIMICROBIAL AGENTS | AVENTIS PHARMA S.A. (FR) | 2001-06-07 | — | — | WO | disclosed |